File Archive - Benzodiazepines Documents - CONTRIBUTION OF THE N-GLUCURONIDATION PATHWAY TO THE OVERALL IN VITRO METABOLIC CLEARANCE OF MIDAZOLAM IN HUMANS (2008)

News Groups Blog Forum Chat Video Audio Images Documents Wiki Home

		Drugs Forum > File Archive > Documents > CHEMICAL & (SEMI-) SYNTHETIC DRUGS > Downers Documents > Benzodiazepines Documents
CONTRIBUTION OF THE N-GLUCURONIDATION PATHWAY TO THE OVERALL IN VITRO METABOLIC CLEARANCE OF MIDAZOLAM IN HUMANS (2008)

Tags

FAQ n Rules

Mark Forums Read

Notices

Create a FREE account now to get access to more forums, more videos, more music, more documents, more images, more reviews, more news about drugs and much more functionality.
Start posting now, join our groups or create your unique profile.

links

Benzodiazepines Documents

New entries announced in forum Downers and sleeping pills

Allowances: 4.88 Mbytes/1.40 Mbytes used

[RSS Feed]

Entries

CONTRIBUTION OF THE N-GLUCURONIDATION PATHWAY TO THE OVERALL IN VITRO METABOLIC CLEARANCE OF MIDAZOLAM IN HUMANS (2008)

Left click: open entry/Right click: save entry

Drug Metabolism and Disposition 2008 Feb 6
(e-published)

Klieber S, Hugla S, Ngo R, Arabeyre-Fabre C, Meunier V, Sadoun F, Fedeli O, Rival M, Bourrie M, Guillou F, Maurel P, Fabre G

Midazolam is one of the most commonly used in vivo and in vitro CYP3A4 probe substrate for drug-drug interactions (DDI) studies. The major metabolic pathway of midazolam in humans consists in the CYP3A4 mediated 1'-hydroxylation followed by urinary excretion as 1'-O-glucuronide derivative. In the present study, following incubation of midazolam with human liver microsomes supplemented with UDPGA, two major HPLC peaks were isolated. HPLC and LC-MS/MS analyses identified these two metabolites as quaternary direct N-glucuronides of midazolam thus revealing an additional metabolic pathway for midazolam. (1)H NMR spectrometry studies were performed demonstrating that these two glucuronides were beta-N-glucuronides, which could be considered as two different conformers of the same molecule. According to molecular modelling experiments, the two glucuronide derivatives could be involved in atropoisomerism equilibrium. The formation of midazolam N-glucuronide exhibited moderate intersubject variability (at most 4.5-fold difference, n = 10). Among the recombinant human UGTs isoforms tested, only isoform UGT1A4 catalyzed the N-glucuronidation of midazolam fitting a Michaelis-Menten model. Km and Vmax values were of 29.9 +/- 2.4 microM and 659.6 +/- 19.0 pmol/min/mg protein, respectively. The N-glucuronide derivative was found in human hepatocytes incubated under control conditions but also in the presence of the well-known CYP3A4 inhibitor, ketoconazole. In the context of the in vitro study of CYP3A4-mediated DDI using midazolam and ketoconazole, direct midazolam N-glucuronidation may partly compensate the decrease in midazolam metabolic clearance caused by the addition of the inhibitor thus potentially leading to under-estimation, at least in vitro, of the extent of DDI

Discussion Thread

Category Benzodiazepines Documents

Submitted by Jatelka

12-03-2008
1017.31 Kbytes Hits 6
Keywords: midazolam p[harmacology cytochrome

Category

Forum Jump

Sitelinks:	Site Functions:
Homepage Wiki Documents Image Gallery Audio Video Forum Blog Groups News	Site Rules Frequently Asked Questions Register to Participate Did you forget your password? All Threads

All times are GMT +1. The time now is 04:27.